NCT01673620View on ClinicalTrials.gov

A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484)

PHASE3CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

July 4, 2012

Primary Completion Date

October 10, 2012

Study Completion Date

October 10, 2012

Conditions
Allergic Rhinitis
Interventions
DRUG

Montelukast 10 mg/loratadine 10 mg

Montelukast 10 mg/loratadine 10 mg tablet administered once daily

DRUG

Placebo

Matching placebo tablet administered once daily

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT01673620 - A Study to Evaluate the Safety of Combination Montelukast/Loratadine in Mexican Participants With Allergic Rhinitis (MK-0476A-484) | Biotech Hunter | Biotech Hunter